B. Riley Securities Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $290

Benzinga Newsdesk www.benzinga.com Neutral 57.9%

Neg 0% Neu 57.9% Pos 0%

B. Riley Securities analyst Anderson Schock initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $290.